Using mode of action information to improve regulatory decision-making: An ECETOC/ILSI RF/HESI workshop overview

References

• Beane Freeman LE, Blair A, Lubin JH, Stewart PA, Hayes RB, Hoover RN, Hauptmann M. (2009). Mortality from lymphohematopoietic malignancies among workers in formaldehyde industries: The National Cancer Institute Cohort. J Natl Ccaner Inst 101:751–761.
   PubMedGoogle Scholar
• Boobis AR, Cohen SM, Dellarco V, McGregor D, Meek ME, Vickers C, Willcocks D, Farland W. (2006). IPCS framework for analyzing the relevance of a cancer mode of action for humans. Crit Rev Toxicol 36:781–792.
   PubMed Web of Science ®Google Scholar
• Boobis AR, Doe JE, Heinrich-Hirsch B, Meek ME, Munn S, Ruchirawat M, Schlatter J, Seed J, Vickers C. (2008). IPCS framework for analyzing the relevance of a noncancer mode of action for humans. Crit Rev Toxicol 38:87–96.
   PubMed Web of Science ®Google Scholar
• Butterworth BE. (2006). A classification framework and practical guidance for establishing a mode of action for chemical carcinogens. Regul Toxicol Pharmacol 45:9–23.
   PubMedGoogle Scholar
• Dellarco VL, Baetcke K. (2005). A risk assessment perspective: Application of mode of action and human relevance frameworks to the analysis of rodent tumor data. Toxicol Sci 86:1–3.
   PubMed Web of Science ®Google Scholar
• ECETOC. (2006). Toxicological Modes of Action: Relevance for Human Risk Assessment. Technical Report No. 99. Brussels: European Centre for Ecotoxicology and Toxicology of Chemicals; July 2006.
   Google Scholar
• ECETOC. (2007). Cyanides of Hydrogen, Sodium and Potassium, and Acetone Cyanohydrin. JACC Report No. 53. Brussels: European Centre for Ecotoxicology and Toxicology of Chemicals; September 2007.
   Google Scholar
• EU. (2006). Directive 2006/121/ec of the European Parliament and of the Council of 18 December 2006 amending Council Directive 67/548/EEC on the approximation of laws regulations and administrative provisions relating to the classification packaging and labelling of dangerous substances in order to adapt it to Regulation (EC) No. 1907/2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) and establishing a European Chemicals Agency.
   Google Scholar
• EC. (2008). Regulation (EC) No. 1272/2008 of the European Parliament and of the Council of 16 December 2008 on classification, labelling and packaging of substances and mixtures, amending and repealing Directives 67/548/EEC and 1999/45/EC and amending Regulation (EC) No. 1907/2006.
   Google Scholar
• ECB. (2003). Technical Guidance Document in support of Commission Directive 93/67/EEC on risk assessment for new notified substances, Commission Regulation (EC) No. 1488/94 on risk assessment for existing substances and Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market. Ispra, Italy: European Chemicals Bureau, Institute for Health and Consumer Protection, European Commission Joint Research Centre. Available at: http://ecb.jrc.ec.europa.eu/tgd/ available on 5 Jan 2011.
   Google Scholar
• ECB. (2008). Risk Assessment Vinyl Acetate, CAS-No.: 108-05-4 EINECS-No.: 203-545-4. Ispra, Italy: European Chemicals Bureau, Institute for Health and Consumer Protection, European Commission Joint Research Centre. Luxembourg: Office for Official Publications of the European Communities. Available at: http://ecb.jrc.ec.europa.eu/esis/.
   Google Scholar
• Edwards SW, Preston RJ. (2008). Systems biology and mode of action based risk assessment. Toxicol Sci 106:312–318.
   PubMed Web of Science ®Google Scholar
• EFSA. (2005). European Food Safety Authority. Opinion of the Scientific Committee on a harmonized approach for risk assessment of substances which are both genotoxic and carcinogenic. http://www.efsa.europa.eu/en/scdocs/scdoc/282.htm.
   Google Scholar
• European Medicines Agency. (2007). Guideline on Strategies to Identify and Mitigate Risks for First-in Human Clinical Trials with Investigational Medicinal Products. EMEA/CHMP/SWP/28367/07. London: European Medicines Agency.
   Google Scholar
• FDA. (2010). US Food and Drug Administration. Guidance for Industry M3(R2). Nonclinical Safety Studies for the Conduct of Human Clinical Trials and Marketing Authorization for Pharmaceuticals. Washington, DC: US Food and Drug Administration.
   Google Scholar
• Hall MG, Wilks MF, Provan WM, Eksborg S, Lumholtz B. (2001). Pharmacokinetcs and pharmacodynamics of NTBC (2-(2-nitro-4-fluoromethylbenzoyl)-1,3-cyclohexanedione) and mesotrione, inhibitors of 4-hydroxyphenyl pyruvate dioxygenase (HPPD) following a single dose to healthy male volunteers. Br J Clin Pharmacol 52:169–177.
   PubMed Web of Science ®Google Scholar
• Hattis D, Chu M, Rahmioglu N, Goble R, Verma P, Hartman K, Kozlak M. (2009). A preliminary operational classification system for nonmutagenic modes of action for carcinogenesis. Crit Rev Toxicol 39:97–138.
   PubMed Web of Science ®Google Scholar
• Hill AB. (1965). The environment and disease: Association or causation? Proc R Soc Med 58:295–300.
   PubMed Web of Science ®Google Scholar
• IARC. (1995). International Agency for Research on Cancer. Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Dry Cleaning, Some Chlorinated Solvents and Other Industrial Chemicals. 63: Vinyl Acetate. Lyon, France: IARC.
   Google Scholar
• IARC. (2006). International Agency for Research on Cancer. Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Formaldehyde, 2-Butoxyethanol and 1-tert-Butoxypropan-2-ol. 88: Formaldehyde. Lyon, France: IARC.
   Google Scholar
• ICH. (2005). International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. The Non-Clinical Evaluation of the Potential for Delayed Ventricular Repolarization (QT Interval Prolongation) by Human Pharmaceuticals. Guideline S7B. May 2005.
   Google Scholar
• ICH. (2009). International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. Addendum to ICH S6: Preclinical Safety Evaluation of Biotechnology-Derived Pharmaceuticals S6(R1). October 2009.
   Google Scholar
• Im H, Oh E, Mun J, Khim JY, Lee E, Kang HS, Kim E, Kim H, Won NH, Kim YH, Jung WW, Sul D. (2006). Evaluation of toxicological monitoring markers using proteomic analysis in rats exposed to formaldehyde. J Proteome Res 5:1354–1366.
   PubMed Web of Science ®Google Scholar
• IPCS (International Programme on Chemical Safety). (2005). Chemical-Specific Adjustment Factors for Interspecies Differences and Human Variability: Guidance Document for Use of Data in Dose/Concentration–Response Assessment. Harmonization Project Document No. 2. Geneva: World Health Organization.
   Google Scholar
• Johnson MK. (1969). A phosphorylation site in brain and the delayed neurotoxic effect of some organophosphorus compounds. Biochem J 111:487–495.
   PubMed Web of Science ®Google Scholar
• Julien E, Boobis AR, Olin SS. (2009). The Key Events Dose-Response Framework: A cross-disciplinary mode-of-action based approach to examining dose-response and thresholds. Crit Rev Food Sci Nutr 49:682–689.
   PubMed Web of Science ®Google Scholar
• Lambert JC, Lipscomb JC. (2007). Mode of action as a determining factor in additivity models for chemical mixture risk assessment. Regul Toxicol Pharmacol 49:183–194.
   PubMed Web of Science ®Google Scholar
• Lilienblum W, Dekant W, Foth H, Gebel T, Hengstler JG, Kahl R, Kramer P-J, Schweinfurth H, Wollin K-M. (2008). Alternative methods to safety studies in experimental animals: Role in risk assessment of chemicals under the new European Chemicals Legislation (REACH). Arch Toxicol 82:211–236.
   PubMed Web of Science ®Google Scholar
• Lock EA, Gaskin P, Ellis M.K, Provan WM, Robinson M, Smith LL, Prisbylla MP, Mutter LC. (1996). Tissue distribution of 2-(2-nitro-4-trifluoromethylbenzoyl)cyclohexanedione (NTBC): Effect on enzymes involved in tyrosine catabolism and relevance to ocular toxicity in the rat. Toxicol Appl Pharmacol 141:439–447.
   PubMed Web of Science ®Google Scholar
• Lock EA, Smith LL. (2003) The role of mode of action studies in extrapolating to human risks in toxicology. Toxicol Lett 140–141:317–322.
   Google Scholar
• Lu K, Collins LB, Ru H, Bermudez E, Swenberg JA. (2010). Distribution of DNA adducts caused by inhaled formaldehyde is consistent with induction of nasal carcinoma but not leukemia. Toxicol Sci 116:441–451.
   PubMed Web of Science ®Google Scholar
• Meek ME. (2009). Mode of Action Frameworks in Toxicity Testing and Chemical Risk Assessment. PhD dissertation, Institute for Risk Assessment Sciences (IRAS), Utrecht University, The Netherlands.
   Google Scholar
• Meek ME, Bucher JR, Cohen SM, DeMarco V, Hill RN, Lehman-McKeeman LD, Longfellow DG, Pastoor T, Seed J, Patton DE. (2003). A framework for human relevance analysis of information on carcinogenic modes of action. Crit Rev Toxicol 33:591–654.
   PubMed Web of Science ®Google Scholar
• NRC. (1983). National Research Council: Risk Assessment in the Federal Government. Managing the Process. Washington, DC: National Academy Press.
   Google Scholar
• OECD. (2009). Organisation for Economic Co-operation and Development. Guidance on Grouping of Chemicals: Chemical Categories and Read-Across. Available at: http://www.oecd.org/document/6/03343en_2649_34379_43087494_1_1_1_100.html.
   Google Scholar
• OECD. (2002). Organisation for Economic Co-operation and Development. SIDS. Initial Assessment Report: Formaldehyde. Paris: UNEP Publications.
   Google Scholar
• SCHER. (2008). Scientific Committee on Health and Environmental Risks. Risk assessment report on vinyl acetate, human health part. Adopted November 17, 2008. http://ec.europa.eu/health/archive/ph_risk/committees/04_scher/docs/scher_o_108.pdf.
   Google Scholar
• Ross J, Plummer SM, Rode A, Scheer N, Bower CC, Vogel O, Henderson CJ, Wolf CR, Elcombe CR. (2010). Human constitutive androstane receptor (CAR) and pregnane X receptor (PXR) support the hypertrophic but not the hyperplastic response to the murine nongenotoxic hepatocarcinogens phenobarbital and chlordane in vivo. Toxicol Sci 116:452–466.
   PubMed Web of Science ®Google Scholar
• Seed J, Carney EW, Corley RA, Crofton KM, DeSesso JM, Foster PM, Kavlock R, Kimmel G, Klaunig J, Meek ME, Preston RJ, Slikker W Jr, Tabacova S, Williams GM, Wiltse J, Zoeller RT, Fenner-Crisp P, Patton DE. (2005). Overview: Using mode of action and life stage information to evaluate the human relevance of animal toxicity data. Crit Rev Toxicol 35:663–672.
   Web of Science ®Google Scholar
• SIDS. (2002). Screening Information Data Set. Formaldehyde. Paris: UNEP.
   Google Scholar
• Sonich-Mullin C, Fielder R, Wiltse J, Baetcke K, Dempsey J, Fenner-Crisp P, Grant D, Hartley M, Knaap A, Kroese D, Mangelsdorf I, Meek E, Rice J, Younes M. (2001). IPCS conceptual framework for evaluating a mode of action for chemical carcinogenesis. Regul Toxicol Pharmacol 34:146–152.
   PubMed Web of Science ®Google Scholar
• Speit G, Zeller J, Schmid O, Elhajouji A, Ma-Hock L, Neuss S. (2009). Inhalation of formaldehyde does not induce systemic genotoxic effects in rats. Mutat Res 677:76–85.
   PubMed Web of Science ®Google Scholar
• US EPA. (1996). US Environmental Protection Agency. Proposed guidelines for carcinogen risk assessment. Federal Register 61:17960–18011.
   Google Scholar
• US EPA. (2005). US Environmental Protection Agency. Guidelines for carcinogen risk assessment. Washington, DC: Risk Assessment Forum. EPA/630/P-03001F. Available at: http://www.epa.gov/raf/publications/pdfs/CANCER_GUIDELINES_FINAL_3-25-05.PDF.
   Google Scholar
• US EPA. (2010). IRIS Toxicological Review of Formaldehyde-Inhalation Assessment (External Review Draft). Available at: http://cfpub.epa.gov/ncea/iris_drafts/recordisplay.cfm?deid=223614.
   Google Scholar
• Wang M, Cheng G, Balbo S, Carmella SG, Villalta PW, Hecht SS. (2009). Clear differences in levels of a formaldehyde-DNA adduct in leukocytes of smokers and nonsmokers. Cancer Res 69:7170–774.
   PubMed Web of Science ®Google Scholar
• Williams GM. (2008). Application of mode-of-action considerations in human cancer risk assessment. Toxicol Lett 180:75–80.
   PubMed Web of Science ®Google Scholar
• Yamamoto Y, Moore R, Goldsworthy TL, Negishi M, Maronpot RR. (2004). The orphan nuclear receptor constitutive active/androstane receptor is essential for liver tumor promotion by phenobarbital in mice. Cancer Res 64:7197–7200.
   PubMed Web of Science ®Google Scholar
• Zhang L, Steinmaus C, Eastmond DA, Xin XK, Smith MT. (2009). Formaldehyde exposure and leukemia: A new meta-analysis and potential mechanisms. Mutat Res 681:150–168.
   PubMed Web of Science ®Google Scholar